{"id":"W4403455365","doi":"10.1177/17562848241290636","title":"Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem; National Research, Development and Innovation Office; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Bristol-Myers Squibb; Eli Lilly and Company; Szegedi Tudományegyetem; Emberi Eroforrások Minisztériuma; Celltrion; Teva Pharmaceutical Industries; Gilead Sciences; Amgen; Pfizer; Horizon 2020 Framework Programme","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Internal medicine; Gastroenterology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006586013,0.000272231,0.0002741831,0.0002133574,0.00001766521,0.00001437974,0.0001336273,0.00007947284,0.00002316878],"category_scores_gemma":[0.00000994052,0.0002273057,0.0001207933,0.00006213298,0.00006769899,0.00001923323,0.00004711145,0.00005472954,0.000009079222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002644064,"about_ca_system_score_gemma":0.00008958401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001894065,"about_ca_topic_score_gemma":0.001534347,"domain_scores_codex":[0.9985397,0.0001590783,0.0004002567,0.0004336228,0.00009009007,0.0003772338],"domain_scores_gemma":[0.9994753,0.00003046691,0.00006197287,0.0003282137,0.00001990213,0.00008414482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004597149,0.0002552458,0.9661702,0.00006591593,0.0001203324,0.0005278426,0.0005270727,0.003957816,0.004594664,0.00007780829,0.000001312634,0.01910467],"study_design_scores_gemma":[0.002216317,0.002975237,0.9898802,0.00007336752,0.00007949064,0.00004043235,0.0001529672,0.0004358122,0.000795459,0.0005510729,0.002583943,0.0002157199],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954958,0.002867046,0.0006629606,0.0001222941,0.0002661887,0.0004756153,0.00004847137,0.00002303336,0.00003860024],"genre_scores_gemma":[0.9984397,0.0006409471,0.0001271703,0.0002393579,0.00006791539,0.0003654932,0.00003536847,0.00003290974,0.0000511473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02371001,"threshold_uncertainty_score":0.9269255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005912891383417481,"score_gpt":0.2692807805838435,"score_spread":0.263367889200426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}